Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Planned sale Director sold 281,541 shares at an average $44.76 ($12,601,536)
  2. 4 Planned sale Director sold 212,477 shares at an average $42.93 ($9,121,902)
  3. 4/A Planned sale Director sold 183,834 shares at an average $42.85 ($7,877,091)
  4. 4 Planned sale Director sold 183,834 shares at an average $42.85 ($7,877,091)
  5. 4/A Planned sale Chief Operating Officer sold 40,000 shares at an average $35.09 ($1,403,668)
  6. 4 Planned sale Chief Operating Officer sold 39,950 shares at an average $35.09 ($1,401,902)
  7. 4 Planned sale Chief Operating Officer sold 40,000 shares at an average $33.36 ($1,334,201)
  8. 4 Open-market sale Chief Scientific Officer sold 2,136 shares at $31.34 ($66,942)
  9. 4 Planned sale Chief Medical Officer sold 2,636 shares at $31.27 ($82,428)
  10. 4 Planned sale Chief Operating Officer sold 85,270 shares at an average $30.30 ($2,583,782)
  11. 4 Open-market sale Chief Business Officer sold 1,823 shares at $31.34 ($57,133)
  12. 4 Planned sale SVP, Head of Finance & Admin. sold 2,921 shares at an average $30.74 ($89,779)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Planned sale Chief Scientific Officer sold 30,426 shares at an average $32.96 ($1,002,751)
  20. 4 Planned sale Chief Scientific Officer sold 2,705 shares at an average $28.27 ($76,469)

Page 8 of 19 · 361 filings